-
1.发明授权Salts of sitagliptin, process for the preparation and pharmaceutical composition therefore 有权西他列汀的盐，因此制备方法和药物组合物公开(公告)号：US09181256B2
公开(公告)日：2015-11-10
申请号：US13985490
申请日：2012-10-12
发明人： Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla , Vamsee Krishna Muppidi , Satyanarayana Chava
IPC分类号： C07D487/04 , A61K31/4985 , C07C57/42
CPC分类号： C07C57/42 , A61K31/4985 , C07D487/04
摘要： The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.
摘要翻译： 本发明涉及西格列汀的药学上可接受的酸加成盐，特别是西格列汀的抗氧化酸加成盐及其制备方法。 本发明还提供了使用西格列汀的药学上可接受的酸加成盐的药物组合物。
-
公开(公告)号：US10730859B2
公开(公告)日：2020-08-04
申请号：US15034797
申请日：2014-11-05
发明人： Satyanarayana Chava , Seeta Rama Anjaneyulu Gorantla , Venkata Sunil Kumar Indukuri , Sanjay Kumar Dehury , Nagaraju Mekala , Jahangeer Baba Shaik , Durga Prasad Kuchipudi
IPC分类号： C07D403/12
摘要： The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
-
3.发明授权公开(公告)号：US10364269B2
公开(公告)日：2019-07-30
申请号：US15573912
申请日：2016-05-21
发明人： Sanjay Kumar Dehury , Nagaraju Mekala , Jahangeer Baba Shaik , Srinivasa Rao Buddepu , Lakshmi Kanth Kola , Venkata Sunil Kumar Indukuri , Seeta Rama Anjaneyulu Gorantla , Satyanarayana Chava
IPC分类号： C07K5/103 , A61K47/42 , C07C271/22 , C07D303/36 , C07C271/16 , C07C271/18 , A61K9/00 , A61K38/07
摘要： The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
-
4.发明申请公开(公告)号：US20190085026A1
公开(公告)日：2019-03-21
申请号：US15573912
申请日：2016-05-21
发明人： Sanjay Kumar Dehury , Nagaraju Mekala , Jahangeer Baba Shaik , Srinivasa Rao Buddepu , Lakshmi Kanth Kola , Venkata Sunil Kumar Indukuri , Seeta Rama Anjaneyulu Gorantla , Satyanarayana Chava
IPC分类号： C07K5/103
CPC分类号： C07K5/1008 , A61K9/0019 , A61K38/07 , C07C271/16 , C07C271/18 , C07C271/22 , C07D303/36
摘要： The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
-
公开(公告)号：US20170313662A1
公开(公告)日：2017-11-02
申请号：US15516206
申请日：2015-10-01
发明人： Kameswar Rao Chivukula , Veera Karuturi , Rao Venkateswara , Srinivas Benda , Ramachandra Anke , Dharmapuri Gajula , Venkata Rama Krishna Murt Moturu , Venkata Sunil Kumar Indukuri , Seeta Rama Anjaneyulu Gorantla , Satyanarayana Chava
IPC分类号： C07D233/86 , C07C25/13 , C07C22/08 , C07C331/28 , C07C255/49 , C07C2601/16
CPC分类号： C07D233/86 , C07C22/08 , C07C25/13 , C07C255/49 , C07C331/28 , C07C333/08 , C07C335/22 , C07C335/26 , C07C2601/16
摘要： The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.
-
6.发明授权公开(公告)号：US09206163B2
公开(公告)日：2015-12-08
申请号：US14381546
申请日：2013-03-22
发明人： Sanjay Kumar Dehury , Venkata Lakshmi Narasimha Dammalapati , Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla
IPC分类号： C07D403/06 , A61K31/404 , C07C53/134 , C07C55/07 , C07C55/10 , C07C59/245
CPC分类号： C07D403/06 , A61K31/404 , C07C53/134 , C07C55/07 , C07C55/10 , C07C59/245
摘要： The present invention relates to an improved process for the preparation of Sunitinb. The process involves the activation of 5-((Z)-(5-fluoro-2-oxoindolin-3-ylidene) methyl)-2,4-dimethyl-1 H-pyrrole-3carboxylic acid to corresponding suitable carboxylic acid activating group. The present invention also relates to novel acid addition salts of Sunitinb and preparation thereof.
摘要翻译： 本发明涉及一种改进的Sunitinb的制备方法。 该方法涉及5 - （（Z） - （5-氟-2-氧代二氢吲哚-3-亚基）甲基）-2,4-二甲基-1H-吡咯-3-羧酸与相应的适合的羧酸活化基团的活化。 本发明还涉及新丝氨酸的新型酸加成盐及其制备方法。
-
7.发明授权Salts of sitagliptin, process from the preparation and pharmaceutical composition therefore 有权西他列汀的盐，因此从制剂和药物组合物的过程公开(公告)号：US09388113B2
公开(公告)日：2016-07-12
申请号：US14872210
申请日：2015-10-01
发明人： Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla , Vamsee Krishna Muppidi , Satyanarayana Chava
IPC分类号： C07C57/44 , C07C57/42 , C07D487/04
CPC分类号： C07C57/42 , A61K31/4985 , C07D487/04
摘要： The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.
摘要翻译： 本发明涉及西格列汀的药学上可接受的酸加成盐，特别是西格列汀的抗氧化酸加成盐及其制备方法。 本发明还提供了使用西格列汀的药学上可接受的酸加成盐的药物组合物。
-
公开(公告)号：US09382207B2
公开(公告)日：2016-07-05
申请号：US14423464
申请日：2013-08-22
发明人： Srinivas Simhadri , Yaseen Mohammad , Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla
IPC分类号： C07D213/56 , C07D213/42
CPC分类号： C07D213/56 , C07D213/42
摘要： The present invention relates to an improved process for the preparation of Atazanavir bisulfate Form A. The present invention also relates to a pharmaceutical composition using the Atazanavir bisulfate Form A of the invention.
摘要翻译： 本发明涉及一种制备阿扎那韦形式A的改进方法。本发明还涉及使用本发明的阿扎那韦形式的硫酸氢盐A型的药物组合物。
-
9.发明申请Salts of Sitagliptin, Process from the Preparation and Pharmaceutical Composition Therefore 有权西他列汀的盐，因此制备和药物组合物的过程公开(公告)号：US20160122274A1
公开(公告)日：2016-05-05
申请号：US14872210
申请日：2015-10-01
发明人： Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla , Vamsee Krishna Muppidi , Satyanarayana Chava
IPC分类号： C07C57/42 , C07D487/04
CPC分类号： C07C57/42 , A61K31/4985 , C07D487/04
摘要： The present invention relates to pharmaceutically acceptable acid addition salts of sitagliptin, in particular anti-oxidant acid addition salts of sitagliptin and a process for its preparation. The present invention also provides a pharmaceutical composition using the pharmaceutically acceptable acid addition salts of sitagliptin.
摘要翻译： 本发明涉及西格列汀的药学上可接受的酸加成盐，特别是西格列汀的抗氧化酸加成盐及其制备方法。 本发明还提供了使用西格列汀的药学上可接受的酸加成盐的药物组合物。
-
公开(公告)号：US20150183742A1
公开(公告)日：2015-07-02
申请号：US14423464
申请日：2013-08-22
发明人： Srinivas Simhadri , Yaseen Mohammad , Venkata Sunil Kumar Indukuri , Seeta Ramanjaneyulu Gorantla
IPC分类号： C07D213/56
CPC分类号： C07D213/56 , C07D213/42
摘要： The present invention relates to an improved process for the preparation of Atazanavir bisulfate Form A. The present invention also relates to a pharmaceutical composition using the Atazanavir bisulfate Form A of the invention.
摘要翻译： 本发明涉及用于制备阿扎那韦硫酸氢盐形式A的改进方法。本发明还涉及使用本发明的阿扎那韦形式A的药物组合物。
-
-
-
-
-
-
-
-
-
搜索结果
11 条记录 (耗时 0.02 秒)
